MRRS adds "Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" latest studies, published in November 2016. It is a professional and in-depth study.

The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD. On the basis of end user, it is divided into patients and R&D. In terms of geography, the market is analyzed into North America, Europe, Asia-Pacific, and LAMEA.

North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.

Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its “SmartTurbo” and “SmartTouch” devices in Canada, thereby expanding its product portfolio.

Key players operating in the market include:

Adherium Limited
Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
Propeller Health
Cohero Health, LLC
OPKO Health, Inc. (Inspiro Medical Ltd.)
GlaxoSmithKline plc
Novartis AG
AstraZeneca plc
Boehringer Ingelheim GmbH
Vectura Group plc

KEY BENEFITS FOR STAKEHOLDERS:

The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.
The report presents three different market scenarios for smart inhalers, both for value and volume, based on rapid growth, diminishing growth, and moderate growth scenarios.
Quantitative analysis of the current market and estimations from 2016 to 2022 is presented to help the manufacturers of smart inhalers to analyze the market.
Entire projections presented in the report highlight the market potential, both in terms of value and volume.
The report conducts extensive analysis of the market by closely following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS:

By Product

Inhalers
Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Nebulizers

By Indication

Asthma
COPD
By End User
Patients
R&D

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
UAE
Rest of LAMEA


Browse Complete Report with TOC @
[URL]http://www.marketresearchreportstore.com/shop/smart-inhalers-market-by-product-inhalers-and-nebulizers-dry-powder-inhalers-dpis-metered-dose-inhalers-mdis-indication-asthma-and-copd-end-user-patients-and-r-and-d-global-opportunity[/URL]


Any questions, please feel free to contact us:

Tel: +00-1-626-3463946 - U.S

Email: [email protected]

[URL]http://www.marketresearchreportstore.com/[/URL]